An Overview of Chemistry, Kinetics, Toxicity and Therapeutic Potential of Boldine in Neurological Disorders

被引:6
|
作者
Akotkar, Likhit [1 ]
Aswar, Urmila [1 ]
Ganeshpurkar, Ankit [2 ]
Raj, Ritik [3 ]
Pawar, Atmaram [4 ]
机构
[1] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmacol, Pune 411038, Maharashtra, India
[2] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Chem, Pune 411038, India
[3] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut Biotechnol, Pune 411038, India
[4] Bharati Vidyapeeth Deemed Univ, Poona Coll Pharm, Dept Pharmaceut, Pune 411038, India
关键词
Alkaloids; Antioxidant; Boldine; Aporphine; Neuroprotective; Toxicity; SPINAL-CORD-INJURY; MICROSOMAL LIPID-PEROXIDATION; OXIDATIVE STRESS; IN-VITRO; ALKALOID BOLDINE; PEUMUS-BOLDUS; ANTIOXIDANT ACTIVITY; APORPHINE ALKALOIDS; STATUS EPILEPTICUS; CELL-DEATH;
D O I
10.1007/s11064-023-03992-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Boldine is an alkaloid obtained from the medicinal herb Peumus boldus (Mol.) (Chilean boldo tree; boldo) and belongs to the family Monimiaceae. It exhibits a wide range of pharmacological effects such as antioxidant, anticancer, hepatoprotective, neuroprotective, and anti-diabetic properties. There is a dearth of information regarding its pharmacokinetics and toxicity in addition to its potential pharmacological activity. Boldine belongs to the aporphine alkaloid class and possesses lipophilic properties which enable its efficient absorption and distribution throughout the body, including the central nervous system. It exhibits potent free radical scavenging activity, thereby reducing oxidative stress and preventing neuronal damage. Through a variety of neuroprotective mechanisms, including suppression of AChE and BuChE activity, blocking of connexin-43 hemichannels, pannexin 1 channel, reduction of NF-& kappa;& beta; mediated interleukin release, and glutamate excitotoxicity which successfully reduces neuronal damage. These results point to its probable application in reducing neuroinflammation and oxidative stress in epilepsy, Alzheimer's disease (AD), and Parkinson's disease (PD). Moreover, its effects on serotonergic, dopaminergic, opioid, and cholinergic receptors were further investigated in order to determine its applicability for neurobehavioral dysfunctions. The article investigates the pharmacokinetics of boldine and reveals that it has a low oral bioavailability and a short half-life, requiring regular dosage to maintain therapeutic levels. The review studies boldine's potential therapeutic uses and mode of action while summarizing its neuroprotective benefits. Given the favorable results for boldine as a potential neurotherapeutic drug in laboratory animals, more research is required. However, in order to optimise its therapeutic potential, it must be more bioavailable with fewer detrimental side effects.
引用
收藏
页码:3283 / 3295
页数:13
相关论文
共 50 条
  • [31] Therapeutic potential of berries in age-related neurological disorders
    Norouzkhani, Narges
    Afshari, Shaghayegh
    Sadatmadani, Sayedeh-Fatemeh
    Mollaqasem, Mohammad Mahdi
    Mosadeghi, Shakila
    Ghadri, Hani
    Fazlizade, Safa
    Alizadeh, Keyvan
    Javar, Pouyan Akbari
    Amiri, Hamidreza
    Foroughi, Elaheh
    Ansari, Arina
    Mousazadeh, Kourosh
    Davany, Bozorgmehr Abdullahzadeh
    Kohnehshahri, Ata Akhtari
    Alizadeh, Alaleh
    Dadkhah, Parisa Alsadat
    Poudineh, Mohadeseh
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Therapeutic potential of cinnamon for neurological disorders: A mini-review
    Ahmadi, Ali
    Naziri, Mahdyieh
    Fallahpour, Fatemeh
    Gholami, Kosar
    Arabpour, Javad
    Pazeshgare, Fateme
    Akbarzadeh, Diba
    Ansari, Arina
    Sabri, Hamoun
    Deravi, Niloofar
    NEUROLOGY ASIA, 2022, 27 (01) : 1 - 17
  • [33] Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders
    Gasior, M
    Carter, RB
    Witkin, JM
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (03) : 107 - 112
  • [34] NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders
    Chu, Chengyan
    Gao, Yue
    Lan, Xiaoyan
    Thomas, Aline
    Li, Shen
    NEUROCHEMICAL RESEARCH, 2018, 43 (09) : 1714 - 1722
  • [35] Modulation of glutamate transporters as a potential therapeutic intervention for neurological disorders
    Reeb, Katelyn L.
    Mortensen, Ole V.
    Fontana, Andreia C. K.
    FASEB JOURNAL, 2022, 36
  • [36] Emendation of autophagic dysfuction in neurological disorders: a potential therapeutic target
    Sainani, Shivani R.
    Pansare, Prajakta A.
    Rode, Ketki
    Bhalchim, Vrushali
    Doke, Rohit
    Desai, Shivani
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022, 132 (05) : 466 - 482
  • [37] AIDS AND NEUROLOGICAL DISORDERS - AN OVERVIEW
    ELDER, GA
    SEVER, JL
    ANNALS OF NEUROLOGY, 1988, 23 : S4 - S6
  • [38] Neurological disorders in Libya: An overview
    Benamer, Hani T. S.
    NEUROEPIDEMIOLOGY, 2007, 29 (3-4) : 143 - 149
  • [39] An Overview of Curcumin in Neurological Disorders
    Kulkarni, S. K.
    Dhir, A.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 72 (02) : 149 - 154
  • [40] An overview of neurological disorders in Wales
    Jader, Layla
    NEUROEPIDEMIOLOGY, 2007, 28 (02) : 65 - 78